BARDA seeks to establish a long-term partnership centered around the development of a broad preparedness and response capability that can be rapidly and flexibly leveraged toward vaccine development for pandemic influenza or other priority pathogen threats.  BARDA envisions an initial focus on influenza mRNA vaccine development that complements existing pandemic influenza response capabilities. As the program matures beyond licensure of influenza vaccines, there will be increased focus on continually ‘exercising’ preparedness and response efforts at small scale to ensure readiness to rapidly pivot to address pandemic influenza or any other emerging infectious disease that poses a threat.  The penultimate goal for this program is to serve as a critical component of the Nation’s pandemic response for influenza and any other emerging infectious diseases, collaboratively working with BARDA to develop multiple products using a single, flexible platform capability.

All proposal responses are due January 31, 2025, by 1pm Eastern.

All RRPV submissions must be submitted to the BARDA Digital Resources (BDR) RRPV Portal.

The account request process is simple but may take several days for approval and access. To request a BDR RRPV Portal account (first-time user), please contact the RRPV (RRPV@ati.org) and provide a set of basic information (first and last name, email address, and member organization).

Documentation and reference materials for the BDR RRPV Portal are available to RRPV Member Organizations from the RRPV Members Only Site (for new users, request access here), and upon request from RRPV@ati.org.

Neither the Government nor the RRPV CMF will make allowances/exceptions for submission problems encountered by the Offeror using system-to-system interfaces. If the Offeror fails to submit the full submission prior to the deadline, the submission may not be accepted. It is the Offeror’s responsibility to ensure a timely and complete submission. Failure to propose your submission on time for any reason may result in the submission not being considered for award.

Amendment 02 Release:

Issued: 19 November 2024

Changes: Revises Proposal Responses Due Date to 1/31/2025, 1pm Eastern

Amendment 01 Release: 

Issued: 28 October 2024

Changes: Revises Supplemental Questions Due Date to 11/8/2024 and adds section 4.4.0 Out of Scope

View Amendment 01 Here

Original RPP Release:

Issued: 30 August 2024

Due: 16 December 2024, by 1pm Eastern

View the Original RPP Here